TCL Archive NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending July 12, 2013
TCL Archive Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response November 29, 2013
TCL Archive Acting NIH Director Says M.D. Anderson President John Mendelsohn Outlines 10-Point Plan For Cancer Research February 20, 2009
TCL Archive New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet, January 19, 2007
